Management strategies of the interaction between direct oral anticoagulant and drug-metabolizing enzyme inducers

Little is known regarding the management of direct oral anticoagulants (DOACs) in patients with enzyme-inducing drugs (EID). The use of EID may lead to sub-therapeutic concentrations of DOACs and to treatment failure. Thus, many patients on EIDs cannot benefit from the advantages of DOACs. This was...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of thrombosis and thrombolysis 2019-05, Vol.47 (4), p.590-595
Hauptverfasser:	Perlman, Amichai, Hochberg-Klein, Sarit, Choshen Cohen, Lotan, Dagan, Gil, Hirsh-Raccah, Bruria, Horwitz, Ehud, Aldouby-Bier, Gefen, Negev, Tamar, Matok, Ilan, Azoulay, Laurent, Kalish, Yosef, Muszkat, Mordechai
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants Cardiology Disease management Enzymes Hematology Hospitalization Medicine Medicine & Public Health Patients
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!